Breaking News

British Medical Journal Report Reveals that Pfizer Falsified Covid-19 Vaccine Data in Clinical Trials

Print Friendly, PDF & Email
Pfizer-BioNTech seeks full marketing approval from UK for ...

Respected medical journal the British Medical Journal (BMJ) has reported on alleged data integrity issues with clinical trials that were carried out for Pfizer’s Covid-19 vaccine.

The report was based on information sent from a whistleblower that was backed up by others who worked on the trial. The journal wrote that “…the company falsified data, unblinded patients, employed inadequately trained vaccinators, and was slow to follow up on adverse events reported in Pfizer’s pivotal phase III trial.”

Additionally, a former regional director for Ventavia Research Group, Brook Jackson, provided company documents, audio recordings, emails and photos supporting her claims to the BMJ. Ventavia is a company that was contracted by the pharmaceutical firm to help with the decisive trial.

According to Jackson, staff at Ventavia were overwhelmed by the volume of issues they found. She said that she repeatedly voiced her concerns to superiors about problems such as patient safety, data integrity and poor lab management.

To add to this, Jackson also reported her concerns to the FDA. Later the same day, she was fired on the grounds that she was “not a good fit.” She said it was the first time she had been fired during her 20-year research career.

Among the information provided to the BMJ by Jackson was a recording of a late September meeting in which she met with two directors of Ventavia to discuss a possible FDA inspection. One executive said to Jackson: “We’re going to get some kind of letter of information at least, when the FDA gets here … I know it.”

A senior executive can also be heard in the recording explaining that the company could not quantify the number and types of errors that were being identified: “In my mind, it’s something new every day,” the individual said. “We know that it’s significant.”

Another employee confirmed that the company was expecting to be subjected to a federal audit of its trial for the Pfizer jab, but one never materialised. From 2000 to 2005, the FDA only inspected 1 percent of clinical trial sites; in 2020, the agency only carried out 50 onsite visits overall.

The BMJ saw an email that was sent to Ventavia by a research organisation that also partnered with Pfizer for the trial. ICON. The email suggests that ICON was unhappy with Ventavia’s failure to keep up with data entry queries. The organisation reminded Ventavia that they expected all queries to be addressed within 24 hours; more than 100 had remained outstanding at that point for more than three days. Among them included cases in which test subjects reported severe adverse reactions.

In Jackson’s complaint to the FDA, she listed a dozen problems that she personally witnessed. Some of the entries included “mislabeled laboratory specimens,” “participants being placed in a hallway after injection and not being monitored by clinical staff,” “vaccines not being stored at proper temperatures,” “protocol deviations not being reported” and “a lack of timely follow-up of patients who experienced adverse events” – along with staff who reported these problems being targeted by Ventavia.

Jackson’s account does not stand alone, however, as other former employees of the company have supported her account, many of whom have since left the company or been fired. Jackson said that an executive who was at the September meeting has since offered her an apology and confirmed that everything she complained about was “spot on.”

The BMJ confirmed several aspects of Jackson’s complaint with two former employees. One revealed that she had worked on more than four dozen clinical trials in her career and had never experienced a work environment like that of the Pfizer trial.

She also said that some of the problems identified by Jackson continued after she left the company. Such as a lack of employees meant that not all trial participants who reported Covid-19 symptoms were swapped for injections.

That employee said she was surprised by the things that were allowed and expected during the trial and added that she doesn’t believe it generated “good clean data.”

Just one of these issues identified by these employees – such as failing to follow up on adverse reactions – should have meant that the vaccine study would have been tossed out. Yet the FDA granted the vaccine full approval.

Share this page to Telegram
5 2 votes
Article Rating
Subscribe
Notify of
guest

31 Comments
Inline Feedbacks
View all comments
Verona McDaniel
Verona McDaniel
10 months ago

I get paid more than $30 to $70 per hour for working online. I heard about this job 3 months ago and after joining this I have earned easily $10k from this without having online working skills . Simply give it a shot on the accompanying site…
Here is I started.…………>> http://Www.NETCASH1.Com

Last edited 10 months ago by Verona McDaniel
Whiskey
Whiskey
10 months ago

I’m yet to hear of one instance where they checked people for antibodies and excluded them from studies of the injection’s effectiveness. If they didn’t even bother to do those tests, their studies are worthless nonsense. They’d essentially be testing how effective the injection is in making people immune to COVID, when they’re already immune to COVID.

Even if they had done them, it wouldn’t have been a complete exclusion of people with prior immunity, though. People can retain the ability to produce antibodies even if they’re not currently producing them. (Meaning the antibody tests wouldn’t have picked up prior immunity in all cases.)

I’ve done medical-related research for years, and I’ve never seen so much unscientific nonsense in my life, as I’m seeing in relation to COVID. There was a study where they compared hydroxychloroquine to vitamin C rather than a placebo, which is the “scientific” version of comparing apples to oranges. So much of it is just unbelievable garbage. It’s concerning. Because, these aren’t mistakes professionals would honestly make. So, either we have a huge chunk of the scientific/medical community that’s inept, or we have a huge chunk of the scientific/medical community that’s corrupt, possibly some combination of both. But, the general public depends on their expertise for their health and safety. Their trust is being horribly betrayed in that regard.

Evil Harry Dread
Evil Harry Dread
Reply to  Whiskey
10 months ago

My guess is both. There is currently no excuse for anyone in the scientific or medical fields to be ignorant of the proper data.
This displays a complete absence of any due diligence, or critical thinking to any degree.
Amazingly, lawyers now have more respect than doctors.

Whiskey
Whiskey
Reply to  Evil Harry Dread
10 months ago

I wouldn’t be surprised if that’s the case with some people. But, there’s also something else going on. I’ve known people who’ve spent more years in the medical industry than I’ve been alive, who have seemed to have forgotten the most basic details of medicine. They’ve forgotten, in the span of a year or two, how infections work, what trials are needed to establish medicinal safety, what masks are used for, and more. It’s unfathomable. Where exactly did that information go? And, it’s not an isolated occurrence, either. Those I know personally, on a normal day, are decent people. But, during all of this? They’ve just helped things along, no matter how unscientific or nonsensical. I don’t know where that might place between ineptitude or corruption. Were I thinking outside the box, I might suggest that our medical industry has something like Stockholm syndrome.

noths
noths
Reply to  Whiskey
10 months ago

They haven’t forgotten anything. They’re just keeping themself face down in the trough of public funds.

trackback
10 months ago

[…] November 9, 2021British Medical Journal Report Reveals that Pfizer Falsified Covid-19 Vaccine Data in Clinical Trial… […]

Evil Harry Dread
Evil Harry Dread
10 months ago

The FDA has NOT granted full approval of Pfizer.
They granted approval of Comirnaty, which doesn’t exist in the US yet.
Which begs the question, how can they approve something that does not yet exist?

trackback
10 months ago

[…] – British Medical Journal Report Reveals that Pfizer Falsified Covid-19 Vaccine Data in Clinical Trial… […]

Paul Prichard
Paul Prichard
10 months ago

Your alternative update on #COVID19 for 2021-11-08. Midazolam Murders to court. Italian IoH drops count f/ 130k+ to 3,783. Jab: kill 200 to ‘save’ one
https://paulthepaperbear.wordpress.com/2021/11/08/your-alternative-update-on-covid19-for-2021-11-08-midazolam-murders-to-court-italian-ioh-drops-count-f-130k-to-3783-jab-kill-200-to-save-one/

trackback
10 months ago

[…] Read More: British Medical Journal Report Reveals that Pfizer Falsified Covid-19 Vaccine Data in Cli… […]

trackback
10 months ago

[…] https://twitter.com/jaketapper/status/1455214615860858882?s=20 CNN host Jake Tapper inadvertently revealed the security theatre that is …November 9, 2021British Medical Journal Report Reveals that Pfizer Falsified Covid-19 Vaccine Data in Clinical Trial… […]

trackback
10 months ago

[…] British Medical Journal Report Reveals that Pfizer Falsified Covid-19 Vaccine Data in Clinical Trial… […]

trackback
10 months ago

[…] https://twitter.com/jaketapper/status/1455214615860858882?s=20 CNN host Jake Tapper inadvertently revealed the security theatre that is …November 9, 2021British Medical Journal Report Reveals that Pfizer Falsified Covid-19 Vaccine Data in Clinical Trial… […]

trackback
10 months ago

[…] we have previously reported, a Pfizer subcontractor is being accused of falsifying data, unblinding patients, hiring […]

trackback
10 months ago

[…] we have previously reported, a Pfizer subcontractor is being accused of falsifying data, unblinding patients, hiring […]

trackback
10 months ago

[…] we have previously reported, a Pfizer subcontractor is being accused of falsifying data, unblinding patients, hiring […]

trackback
10 months ago

[…] of BioNTech took a dramatic 20% plunge in the wake of a damning whistle-blower report.  The whistle-blower, Brook Jackson, claimed that the company hired poorly-trained vaccinators, that it was slow to investigate the […]

trackback
10 months ago

[…] shares of BioNTech took a dramatic 20% plunge in the wake of a damning whistle-blower report.  The whistle-blower, Brook Jackson, claimed that the company hired poorly-trained vaccinators, that it was slow to investigate the […]

trackback
9 months ago

[…] trials have been proved to be fraudulent.  “There is no evidence whatsoever for the efficacy of these gene-based vaccines in protecting […]

trackback
9 months ago

[…] trials have been proved to be fraudulent.  “There is no evidence whatsoever for the efficacy of these gene-based vaccines in protecting […]

trackback
9 months ago

[…] trials have been proved to be fraudulent.  “There is no evidence whatsoever for the efficacy of these gene-based vaccines in protecting […]

trackback
9 months ago

[…] trials have been proved to be fraudulent.  “There is no evidence whatsoever for the efficacy of these gene-based vaccines in […]

trackback
7 months ago

[…] British Medical Journal Report Reveals that Pfizer Falsified Covid-19 Vaccine Data in Clinical Trial…, 9 November 2021 […]

trackback
6 months ago

[…] whistle-blower Brook Jackson is providing evidence for their federal court case. Jackson went to the British Medical […]

trackback
4 months ago

[…] 2 November 2021, the BMJ published information disclosed to them by whistle-blower Brook Jackson, a former regional director for Ventavia Research Group.  Ventavia is a company […]

trackback
4 months ago

[…] 2 November 2021, the BMJ published information disclosed to them by whistle-blower Brook Jackson, a former regional director for Ventavia Research Group.  Ventavia is a company that […]

trackback
4 months ago

[…] 2 November 2021, the BMJ published information disclosed to them by whistle-blower Brook Jackson, a former regional director for Ventavia Research Group.  Ventavia is a company […]

trackback
4 months ago

[…] 2 November 2021, the BMJ published information disclosed to them by whistle-blower Brook Jackson, a former regional director for Ventavia Research Group.  Ventavia is a company […]